Five Compounders, One Benchmark: Who Compounds Most Cleanly in the VMS Universe

Vertical Market Software lures quality investors with the same promise: many small, sticky niches, high switching costs, recurring revenue, and a capital-allocation system that channels cash from mature businesses into new acquisitions. The model is called Constellation Software, and the pattern is so compelling that it has been copied by dozens of spin-offs and clones.

This is exactly where the trap lies. When five companies all work from the same script, the impression arises that they are interchangeably good compounders. They are not. Constellation is the mature quality anchor, Topicus the cleanest European spin-off, Lumine the smaller compounder with a still-open growth runway, CHAPTERS the young platform with the greatest leverage and the most open flanks — and Asseco the special case that shows why operating strength and shareholder value are two different things. They differ not in the idea, but in execution, and above all in how much of the value creation ends up with the shareholder and at what price they buy it.

The comparison has gained additional sharpness since the individual analyses, because the market has cleaned house brutally over the past twelve months. Constellation itself fell roughly 39 percent from its high, Topicus roughly 40 percent, and Lumine has more than halved from over 50 to 22.65 CAD. The trigger was not an operational collapse, but a new worry: whether AI-assisted software development erodes the moats of the thousand niche providers on which the entire model rests. The central question is therefore no longer only which business is the best, but where quality, clean structure, and price coincide again for the first time in a long while after this re-pricing — and whether the AI risk is real or overstated.

This article places the five names side by side and measures them against a single benchmark — the original itself: who compounds most cleanly, today and over the next decade?

The Benchmark: What Makes a Clean Compounder

Before comparing five companies, it must be clear what you measure them against. A clean compounder fulfills four conditions simultaneously, not just individually.

First, it needs a business with real economic substance — high ROIC on operating core capital, high switching costs, recurring revenue. Second, it must be able to reinvest capital at returns well above the cost of capital; not only the core business, but also the capital paid for acquisitions has to earn. Third, the cash generated must actually reach the shareholder of the listed parent and must not leak away through minorities, leverage, or holding structures. And fourth — the point at which most cases fail — the price must still leave enough margin of safety that normal operational fluctuations do not immediately lead to capital loss.

Conveniently, a living textbook example exists for these four conditions. Constellation Software is not just another name on the list — it is the reference against which the other four are measured.

Constellation: the Living Benchmark

What distinguishes Constellation is not a single top metric, but the simultaneity of all four conditions over decades. On the capital currently tied up, the group earns 19.4 percent ROIC; in the more conservative Leonard logic — measured against all capital ever deployed in M&A — still 16.2 percent. Both figures lie well above the cost of capital, with a spread of roughly 9.6 to 12.9 percentage points.

Even more revealing is the third lens: strip out the acquired intangibles entirely and the invested capital of the core business turns negative. Customers pay in advance; the negative working capital helps finance operations. Economically, that means operating capital efficiency is effectively infinite, and the real source of value is not operations, but the decision about what happens to the surplus cash. This is precisely the pure form of the compounder model that the other four only approximate.

It is remarkable that the machine has not stalled at roughly 63 billion CAD in market value. Free cash flow grew at roughly 23 percent annually over eight years, with only a single, marginal down year. This consistency through the full cycle, including the rate-hiking turn, is the strongest empirical argument against the AI bear: so far, nothing has slowed the cash generation.

That is exactly what makes Constellation a useful anchor. Every question to the four spin-offs is, at its core: how close do you come to the original — in quality, in cleanliness, in price? And Constellation itself shows the humility with which one should view the whole field: even the best business is, at today's level, fairly paid at best.

The Five at a Glance

The table reveals a pattern that runs through the entire comparison: operating quality is abundant in the VMS universe. What is scarce are clean capital structures and attractive prices — and after the sell-off, that second point has shifted in buyers' favor for the first time in a long while.

Business Quality: Constellation and Topicus Lead

On the pure business level, the original and its European spin-off lead. Constellation delivers, in the Leonard logic, 16.2 percent return on all M&A capital ever deployed — and a core business that ties up so little capital that it is mathematically capital-negative. Topicus combines a high recurring-revenue share of 71 percent with an operating ROIC of 20.4 percent after Asseco adjustment and cash generation so robust that it makes the reported earnings line almost meaningless. Free cash flow ran at roughly 965 percent of reported earnings in 2025 and grew at roughly 26 percent annually from 2018 to 2025, without a single down year. The fact that the Leonard ROIC of 16.9 percent lies below the operating core is a reminder that on a total-capital basis — including Asseco — some shine is lost.

Asseco is the interesting paradox of the quintet: on operating core capital, the group earns the highest core return of all five at 30.0 percent ROIC. Unfortunately, the high core return is of little use to the shareholder, because it is diluted on the way up — including the purchase price paid, ROIC falls to 12.9 percent, and a large part of what remains belongs to minorities.

Lumine and CHAPTERS are the early-stage representatives. Both have the right DNA — specialized niches, recurring revenue, decentralized leadership — but with a smaller base and a shorter history. At CHAPTERS, the HGB accounting with its forced goodwill amortization completely obscures the economic reality of the ~19 percent core business: reported EBIT is negative, but free cash flow is clearly positive.

Capital Allocation: Where the Difference Between Core and Purchase Price Decides

The most interesting metric is not the ROIC of the core business, but the difference between core ROIC and ROIC on the paid purchase price. It shows whether a compounder deploys capital with discipline or extravagance.

Constellation and Topicus show the healthiest profile here. At Constellation, the proof has long been delivered: even in the conservative Leonard calculation, which accounts for every dollar ever put into M&A, ROIC is 16.2 percent — a spread of roughly 9.6 percentage points over the cost of capital, consistent for decades. Topicus follows with a Leonard ROIC of 16.9 percent; the gap to the operating core is moderate, and the level stays above the cost of capital. That is the mechanism of an allocator that pays for quality but does not overpay.

Asseco reveals the opposite pattern: an excellent core business (30.0 percent) pushed down to 12.9 percent on the capital paid by expensive historical acquisitions. CHAPTERS is the sharpest case — on the purchase price paid, ROIC falls to roughly 4 percent, below the WACC of 7.9 percent. As long as this value lies below the cost of capital, every further debt-financed acquisition mathematically widens the gap, especially since CHAPTERS is the most leveraged of all five at 3.87x net debt/EBITDA.

Who Owns the Profit? The Asseco Trap

This is where the field separates most clearly. A compounder can be as good operationally as it likes — if the profit generated does not reach the shareholder of the listed parent, the business quality is worth only half as much to the investor.

That is the central reason why Asseco, despite the highest core ROIC and the optically lowest multiple, is not a clean compounder. The relevant cash flow is not group cash flow, but the parent-attributable cash flow after minority outflows — and that is far more ordinary than the headline picture.

CHAPTERS suffers from the same problem, only in milder form. Minorities make up roughly 29 percent of group equity, and the largest EBITDA block is owned by CHG only at 61.7 percent. At Constellation, Topicus, and Lumine, this leakage is smallest — owner cash flow is most cleanly attributable here.

The Earnings Line Lies — for Three, in Different Ways

A recurring motif: at these companies, reported net income is a poor guide. The reasons differ.

At Topicus, a 2025 write-down to cost of EUR 221.7 million in the course of the Asseco accounting pushed earnings from 92 to 42 million euros — an accounting effect, not an operational deterioration. At Asseco, the effect works in the opposite direction: reported group net income jumped to PLN 3,628 million in 2025, but the bulk comes from the sale of the Sapiens majority stake — a one-off effect. At CHAPTERS, HGB accounting forces a linear goodwill amortization that produces negative EBIT, while free cash flow stayed positive and grows at a 64 percent CAGR. The reported LTM ROIC of −1.9 percent at TIKR is exactly this artifact.

The lesson for all five: anyone valuing these companies on simple earnings multiples is analyzing the accounting, not the business. Cash flow and ROIC on the right capital are the more reliable lenses. It is no coincidence that the NTM MC/FCF multiple — the price on free cash flow — is the most meaningful valuation line in the summary table.

The Shared Risk: AI Against the Moats

As different as the five are in structure and maturity, they share one risk, and it is the real reason for the sell-off across the entire segment. The VMS model rests on thousands of small niche providers being protected by high switching costs, deep process integration, and a lack of alternatives. The market has been questioning precisely these moats since 2026: if AI-assisted software development lowers the cost of replacing or rebuilding a niche solution, the protection that supports pricing power and customer retention shrinks.

This risk does not hit the five equally. Constellation and Topicus are the most broadly insulated through diversification across thousands and hundreds of end markets, respectively — no single disrupted niche market moves the whole. Lumine is concentrated in the communications and media industry and thus more focused in its exposure. Asseco sits in regulated, often public-sector end markets where replacements are slow and political — which paradoxically protects it. CHAPTERS, meanwhile, is trying to use AI offensively as an opportunity by turning the structured data of its OpCos into new products.

The empirical counterargument so far is provided by the cash generation itself: across the entire rate cycle and even during the ongoing AI hype, free cash flow at Constellation, Topicus, and Lumine has kept growing. So far, nothing has slowed the machine. That does not make the risk smaller, but it puts into perspective the speed at which the moat-erosion thesis would have to show up in the numbers. For the investor, that is the decisive open question — and the reason why even the original is only fair and not cheap today.

Valuation: The Sell-Off Changes the Picture

This is where the most has changed since the individual analyses. Back then, the finding for nearly all the names was: good quality, but no margin of safety. After a year in which the entire segment lost 25 to 40 percent, that statement needs to be differentiated.

The real surprise is the relative valuation. Topicus now trades at 10.65x NTM EV/EBITDA, cheaper than Constellation (11.97x) and cheaper than Lumine (12.03x) — even though it is the more mature and cleaner business than Lumine. After the 40 percent price decline, a margin of safety has emerged at Topicus for the first time in a long while, one that at least partly compensates for the complexity added by Asseco.

Lumine is the other side of the same coin: despite the price halving, it remains the most expensive of the three "clean" businesses at 12.03x and thus still carries a premium that is harder to justify after the lost discovery discount. Asseco, on multiples, is by far the cheapest at 5.85x EV/EBITDA and a 6.1 percent dividend yield — but that is the structural discount, not a substance rebate. And CHAPTERS, at 23.29x EV/EBITDA, is by far the most expensive name in the field; even after a 26 percent price loss, the market is pricing in a successful compounder that still has to grow into its valuation.

Two Questions, Two Rankings

Here it is worth drawing a distinction that the market likes to blur. These five names do not answer the same investor question. Anyone looking for the safest compounder arrives at a different order than anyone looking for the largest possible multi-bagger. Both questions are legitimate — but they lead to different stocks, and most mistakes arise where they are mixed.

Question one: who is the safest, cleanest compounder? Here, the simultaneity of quality, clean structure, and a sensible price counts.

To this question, the answer is calm and clear. Constellation is the best company with the burden of proof already met — but even after the crash without a margin of safety, with a fair value roughly 8 percent below the price. Topicus is the cleanest European quality name and, after a 40 percent price decline at 10.65x EV/EBITDA, the name with the best ratio of quality, structure, and price. Lumine has the same clean mechanism but, at 12.03x, remains the most expensive of the three clear businesses. Asseco and CHAPTERS fall behind on this axis — not because the operating business is weak, but because at Asseco nearly half the profit goes to minorities and CHAPTERS earns less than its cost of capital on the purchase price paid.

Question two: which stock could multiply most strongly from today's point? Here the order reverses — but not as uncritically as it first tempts.

In theory, smaller, not-yet-fully-proven compounders have the longest reinvestment runway and, in the success case, the strongest leverage. By this logic, CHAPTERS moves to the front, with Lumine right behind. Both are small enough that individual successful acquisitions noticeably change the profile — an asymmetry that the mature Constellation can structurally no longer offer.

But this is exactly where one must stay disciplined. CHAPTERS already trades at 23.3x EV/EBITDA — the most expensive multiple in the field. The return source "multiple expansion" is weakest precisely where the multiple is already highest. CHAPTERS' upside therefore does not hang on a re-rating, but on the company growing into its valuation: on margins normalizing, the ROIC incl. breaking through the WACC threshold, and the interest burden staying bearable. That is possible, but it is a bet on execution, not on a mispricing. Lumine is the more measured version of the same idea: smaller than Topicus, with a more open growth runway, but without the expensive multiple and without the leverage question marks of CHAPTERS.

The actual investment case therefore consists in first becoming clear about your own question. Anyone seeking stability holds Constellation as an anchor and uses Topicus as the relatively most attractive entry. Anyone deliberately trading uncertainty for potential looks at Lumine and — with open eyes for the conditions — at CHAPTERS. Asseco remains the special case in both: operationally strong, but interesting as a stock only once the minority ratio structurally declines.

Bear vs. Bull for the Overall Case

Conclusion

Five companies, one script, five very different realities. The popular assumption that every Constellation clone is automatically a good compounder does not hold up to scrutiny. Operating quality is abundant in the VMS universe — Constellation, Topicus, and Asseco even show excellent core returns. But quality alone does not make a good stock, and above all it does not make the same stock.

The case is decided on the levels above, and the most honest answer depends on the question you ask. Anyone seeking the safest, cleanest compounder lands at Constellation as the anchor and Topicus as the relatively most attractive entry — both carried by proven quality, but both at fair, not gifted, prices. Anyone deliberately trading more uncertainty for more potential looks at Lumine and CHAPTERS — with CHAPTERS combining the largest theoretical upside with the most expensive multiple and the highest number of conditions still to be proven. Asseco remains the instructive special case: a good business whose value to the shareholder hangs on the ownership structure, not on the operating strength.

Above all stands the shared AI risk, which explains why even the best business in the field is only fair and not cheap today. The soberest conclusion is therefore: Constellation is the best company. Topicus is the most balanced stock. Lumine is the most interesting smaller quality bet. CHAPTERS is the name with the greatest leverage — and the most conditions. Patience in this universe is not a sacrifice of return. It is part of the return — and after the re-pricing, it is somewhat less necessary in one place than it was a year ago.